Computational model provides caregivers and doctors a better understanding of the potential outcomes for a young child who suffers from a head injury as a result of abuse.
Amyloid beta pathology may be more versatile than previously thought, a new study reports.
A new study reports lower concentrations of α-synuclein in the cerebrospinal fluid of Parkinson's patients is associated with reduced cognitive performance.
Researchers have identified biomarkers that can help predict which patients with Parkinson's disease will suffer from significant cognitive deficits within three years of diagnosis.
Researchers have devised a new blood test that can detect if amyloid had begun to accumulate in the brain. The test help physicians diagnose Alzheimer's disease in a cheaper, less invasive way than currently available. The researchers will present their findings at the Alzheimer's Association International Conference in London.
According to researchers, circadian disruptions can occur years before symptoms of Alzheimer's develop. The findings could help to identify those at risk of developing the neurodegenerative disease as they age.
Researchers have identified average levels of biological and anatomical brain changes associated with Alzheimer's disease over thirty years before symptoms appear. In those with genetic risk factors for Alzheimer's, researchers found changes in cognitive performance up to 15 years before becoming symptomatic. Changes in Tau levels in the cerebral spinal fluid appeared up to 34 years before dementia symptoms occurred, and physical changes to the medial temporal lobe were apparent up to 9 years before cognitive impairment was apparent.